Monoclonal Antibody to Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker)(A53-B/A2.26 + BA17), Clone: [A53-B/A2.26 + BA17], Mouse

Artikelnummer: ABI-36-1388
Artikelname: Monoclonal Antibody to Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker)(A53-B/A2.26 + BA17), Clone: [A53-B/A2.26 + BA17], Mouse
Artikelnummer: ABI-36-1388
Hersteller Artikelnummer: 36-1388
Alternativnummer: ABI-36-1388-100UG
Hersteller: Abeomics
Wirt: Mouse
Kategorie: Antikörper
Applikation: IHC, WB
Spezies Reaktivität: Human
Immunogen: Human breast cancer MCF-7 cells (A53-B/A2), Human mammary epithelial organoids (BA17)
Alternative Synonym: KRT19
This MAb reacts with the rod domain of human cytokeratin-19 (CK19), a polypeptide of 40kDa. CK19 is expressed in sweat gland, mammary gland ductal and secretory cells, bile ducts, gastrointestinal tract, bladder urothelium, oral epithelia, esophagus, and ectocervical epithelium. Anti-CK19 reacts with a wide variety of epithelial malignancies including adenocarcinomas of the colon, stomach, pancreas, biliary tract, liver, and breast. Perhaps the most useful application is the identification of thyroid carcinoma of the papillary type, although 50%-60% of follicular carcinomas are also labeled. Anti-CK19 is a useful marker for detection of tumor cells in lymph nodes, peripheral blood, bone marrow and breast cancer.
Klonalität: Monoclonal
Klon-Bezeichnung: [A53-B/A2.26 + BA17]
NCBI: 3880
UniProt: P08727
Reinheit: Affinity Chromatography
Formulierung: Purified
Target-Kategorie: Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker)
Application Verdünnung: Western Blot (1-2ug/ml),Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 min at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95&degC followed by cooling at RT for 20 mi